NCT01050634View on ClinicalTrials.gov

Sequencing Of Endocrine Therapy In Post-Menopausal Women With Early Breast Cancer (FAST)

CompletedOBSERVATIONAL
Enrollment

980

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2009

Conditions
Post Menopausal Women With Early Breast Cancer
Interventions
DRUG

Aromasin (exemestane)

25mg oral tablet, daily, for \>1yr

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY